Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

医学 结直肠癌 全直肠系膜切除术 累积发病率 外科 放化疗 入射(几何) 临床终点 阶段(地层学) 随机对照试验 癌症 放射治疗 内科学 古生物学 物理 光学 生物 移植
作者
Rolf Sauer,Torsten Liersch,Susanne Merkel,Rainer Fietkau,Werner Hohenberger,Clemens F. Hess,Heinz Becker,Hans-Rudolf Raab,Marie-Therese Villanueva,Helmut Witzigmann,Christian Wittekind,Tim Beißbarth,Claus Rödel
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:30 (16): 1926-1933 被引量:1828
标识
DOI:10.1200/jco.2011.40.1836
摘要

Purpose Preoperative chemoradiotherapy (CRT) has been established as standard treatment for locally advanced rectal cancer after first results of the CAO/ARO/AIO-94 [Working Group of Surgical Oncology/Working Group of Radiation Oncology/Working Group of Medical Oncology of the Germany Cancer Society] trial, published in 2004, showed an improved local control rate. However, after a median follow-up of 46 months, no survival benefit could be shown. Here, we report long-term results with a median follow-up of 134 months. Patients and Methods A total of 823 patients with stage II to III rectal cancer were randomly assigned to preoperative CRT with fluorouracil (FU), total mesorectal excision surgery, and adjuvant FU chemotherapy, or the same schedule of CRT used postoperatively. The study was designed to have 80% power to detect a difference of 10% in 5-year overall survival as the primary end point. Secondary end points included the cumulative incidence of local and distant relapses and disease-free survival. Results Of 799 eligible patients, 404 were randomly assigned to preoperative and 395 to postoperative CRT. According to intention-to-treat analysis, overall survival at 10 years was 59.6% in the preoperative arm and 59.9% in the postoperative arm (P = .85). The 10-year cumulative incidence of local relapse was 7.1% and 10.1% in the pre- and postoperative arms, respectively (P = .048). No significant differences were detected for 10-year cumulative incidence of distant metastases (29.8% and 29.6%; P = .9) and disease-free survival. Conclusion There is a persisting significant improvement of pre- versus postoperative CRT on local control; however, there was no effect on overall survival. Integrating more effective systemic treatment into the multimodal therapy has been adopted in the CAO/ARO/AIO-04 trial to possibly reduce distant metastases and improve survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
GERRARD完成签到,获得积分10
1秒前
做实验太菜完成签到,获得积分10
1秒前
Augusterny完成签到 ,获得积分10
1秒前
鹏gg完成签到,获得积分10
1秒前
愉快书琴完成签到,获得积分10
1秒前
1秒前
小满完成签到,获得积分10
2秒前
科研小秦完成签到,获得积分10
2秒前
2秒前
yanyimeng完成签到,获得积分10
3秒前
半夏黄良完成签到,获得积分10
3秒前
小飞侠07完成签到,获得积分10
3秒前
隐形曼青应助哈h采纳,获得10
4秒前
积极的千琴完成签到,获得积分10
4秒前
kaka发布了新的文献求助10
5秒前
kk完成签到,获得积分10
5秒前
清澜庭完成签到,获得积分10
6秒前
火星上的百川完成签到,获得积分10
6秒前
北过居庸完成签到,获得积分10
6秒前
6秒前
MYZ完成签到,获得积分10
6秒前
众人皆醉我独醒完成签到,获得积分10
6秒前
6秒前
彭于晏应助pups采纳,获得10
6秒前
呆呆完成签到,获得积分10
7秒前
完美世界应助ChiariRay采纳,获得20
7秒前
haru完成签到,获得积分10
8秒前
莫莫莫莫几完成签到,获得积分10
8秒前
曲艺完成签到,获得积分10
8秒前
上官若男应助梁采瑞采纳,获得10
9秒前
烂漫青槐完成签到,获得积分10
9秒前
1107任务报告完成签到,获得积分10
9秒前
Guoshibo完成签到,获得积分10
9秒前
地表飞猪应助菲晗子采纳,获得10
10秒前
米奇的妙妙屋完成签到,获得积分10
10秒前
炸药发布了新的文献求助10
11秒前
小小沙完成签到,获得积分10
11秒前
11秒前
高公子完成签到,获得积分10
11秒前
活泼凡阳发布了新的文献求助10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968608
求助须知:如何正确求助?哪些是违规求助? 3513486
关于积分的说明 11168243
捐赠科研通 3248926
什么是DOI,文献DOI怎么找? 1794540
邀请新用户注册赠送积分活动 875188
科研通“疑难数据库(出版商)”最低求助积分说明 804676